Startups
GlucoTrack is a non-invasive spot measurement glucose monitoring device intended for type 2 and pre-diabetic adults. The Glucotrack is a CE mark class II medical device designed to maximize patient comfort and increase monitoring compliance.
Overview
Location
Israel, Southern, Ashdod Yam
Employees
11-50
Phone
+972 8-675-7878
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 6, 2026 | Glucotrack Secures $5.5 Million Financing Through Equity And Convertible Debt | Glucotrack has entered into definitive agreements for approximately $5.5 million in financing from institutional investors. The deal consists of a $2 million equity financing and a $3.5 million follow-on investment in the form of convertibl... |
| Oct 16, 2025 | TTP Plc extends ISO 13485 certification to contract manufacture of medical devices and IVDs | TTP plc has expanded its ISO 13485 certification to include the contract manufacture of medical devices and in vitro diagnostics, covering implantable and active implantable devices. This extension builds on TTP’s 15-year track record in IS... |
| Feb 4, 2025 | Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering | Rutherford, NJ., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the pricing... |
| Feb 4, 2025 | Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering | Rutherford, NJ., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the pricing... |
| Jan 17, 2025 | Recent Digital Health Executive Hires and Promotions: Medidata Expands Team, CareRev, Philips, Eko Health, Others | AVIZVA, a health-tech organization that offers a variety of solutions for healthcare enterprises, that it has appoints James Vertino as its new CEO. Model N appoints Bret Connor as Chief Executive Officer. The Board of Directors of Blue Shi... |
| Nov 13, 2024 | Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering | Rutherford, NJ., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the launch ... |
| Apr 2, 2024 | GlucoTrack announces increased sensor longevity for its implantable Continuous Blood Glucose Monitor | Rutherford, NJ & Cambridge, UK, April 2, 2024 (GLOBE NEWSWIRE) — GlucoTrack, Inc., a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, and The Technology Par... |
| Mar 12, 2024 | GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY | |
| Apr 17, 2023 | GlucoTrack Closes $10 Million Underwritten Public Offering of Common Stock |
Show more
Reviews 0
FAQ about GlucoTrack Integrity Applications
What has the press written about GlucoTrack Integrity Applications?
Parsers VC has collected 12 articles mentioning GlucoTrack Integrity Applications, among them “Glucotrack Secures $5.5 Million Financing Through Equity And Convertible Debt” (Aug 6, 2026) and “TTP Plc extends ISO 13485 certification to contract manufacture of medical devices and IVDs” (Oct 16, 2025).
Is GlucoTrack Integrity Applications still active?
Yes, GlucoTrack Integrity Applications is active; its latest activity on Parsers VC dates from Sep 12, 2026.